Mbipụta

[30] [Ọhụrụ] Nyocha arụmọrụ nke Goldstream Fungus (1-3) -β-D Glucan

[29] Nyocha nke nchọpụta Cryptococcus capsular polysaccharide FungiXpert LFA maka nyocha ngwa ngwa nke Cryptococcosis.

[28] Uru nchoputa nke akụrụngwa akpaaka zuru oke maka (1-3) -β-d-glucan Test na ndị ọrịa nwere Tumor.

[27] Nyochaa arụmọrụ ụlọ ọgwụ nke nchọpụta Glactomannan Novel Monotest n'ime nchọpụta nke Aspergillosis invasive.

[26] Nnyocha na arụmọrụ nchọpụta nke ọtụtụ usoro Galactomannan dị iche iche maka Aspergillosis na-emerụ ahụ.

[25] Nleba anya na-asọpụta n'azụ jikọtara ya na Immunochromatofraphy Analyzer maka GM Quantative Detection.

[24] Ntụnyere usoro microbiological dị iche iche maka nchọpụta nke Pneumocystis jirovecii ka oyi baa na bronchoalveolar-lavage fuid.

[23] Ileghara ụdịdị mkpụrụ ndụ ihe nketa anya na-egbochi nchoputa nke Cryptococcus Infec n'oge (2)

[22] Nlele nke Carbapenem-Resistant KNIVO Nchọpụta K-Set maka nchọpụta ngwa ngwa nke carbapenemases n'etiti carbapenem na-eguzogide gram-negative bacilli.

[21] Ihe ọ pụtara nchọta nchikota nke Candida mannan na ihe nleba anya n'akụkụ mgbochi mmadụ maka nchoputa candidiasis invasive.

[20] Ihe ọ pụtara nchọta nchikota nke Aspergillus antigen na antibody lateral flow assay maka invasive pulmonary aspergillosis nchoputa.

[19] Ụzọ nchọpụta ọhụụ maka ọrịa fungal - (1,3)-β-D-Glucan Chemiluminescence Immunoassay

[18] Sistemụ Chemiluminescence Immunoassay Sistemụ maka nchọpụta Aspergillus Galactomannan

[17] Nchọpụta izizi nke serum 1,3-β-D-glucan maka pneumocystis jiroveci ka oyi baa, candidiasis invasive, na nyocha usoro nyocha nke aspergillosis na meta-analysis.

[15] Ihe ize ndụ maka nlọghachi nke ọrịa fungal na-emerụ ahụ n'oge prophylaxis antifungal nke abụọ na allogeneic hematopoietic stem cell transplant.

[14] Ọkwa glucan serum na mgbanwe pathological nke ọgwụgwọ antifungal maka ọrịa akụkụ okuku ume ala nke Candida albicans.

[13] Nyochaa Plasma Novel (1,3) -β-d-Glucan Detection Assay for Diagnosis of Candidemia in Pediatric Patient

[12] Platelet Parameters na (1, 3) -β-D-Glucan dị ka ihe nrịbama nchọpụta na ihe nrịbama nke ọrịa fungal na-emerụ ahụ na ụmụ ọhụrụ na-amalitebeghị.

[11] Arụmọrụ nyocha nke Serum 1,3-Beta-D-Glucan n'ime ndị ọrịa nwere ọrịa fungal na-emerụ ahụ A Meta-Analysis of Prospective Cohort Studies

[10] Ọkwa ọbara nke Lipopolysaccharide na 1,3-β-D-Glucan na-ezo aka na ịdị njọ na ndị ọrịa nwere ọrịa Crohn.

[9] Mpụta nke TR46 Y121F T289A na Aspergillus fumigatus dịpụrụ adịpụ site na onye ọrịa China.

[8] ntule nyocha nke Tachypleus amoebocyte lysate maka nchọpụta mmalite nke ọrịa fungal na-efe efe na ICU na China.

[6] Nchọpụta nchọpụta nke (1-3) -β-D-Glucan Assay na Pneumocystitis jirovecii, Aspergillosis Invasive, Mucormycosis, Tuberculosis na Ndị ọrụ afọ ofufo ahụike

[5] Nchọpụta nchọpụta nke nyocha (1-3) -β-Dglucan na ndị ọrịa nwere Pneumocystis.

[4] VALUTAZIONE DI UN NUOVO TEST GOLDSTREAM FUNGUS (1,3)-ß-D-Glucano PER LA DIAGNOSTICA DELLE INFEZIONI FUNGINE INVASIVE.

[3] VALUTAZIONE DI DUE METODICHE KWESỊRỊ IL DOSAGGIO SIERICO DEL 1,3-β-D-GLUCANO NA PAZIENTI A RISCHIO DI INFEZIONI FUNGINE MMADỤ.

[2] Nyocha nke CrAg lateral flow immunoassay maka nyocha nke ndị ọrịa maningitis cryptococcal.

[1] Ụkpụrụ prognostic nke serum galactomannan na (1-3) -beta-D-glucan na ndị ọrịa nọ n'ụlọ ọgwụ nyocha nke mbụ na nsochi nsonazụ.